Danimer Scientific Inc (DNMR)

$2.07

+0.31

(+17.61%)▲

Market is closed - opens 7 PM, 02 Oct 2023

Insights on Danimer Scientific Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 11.92M → 12.86M (in $), with an average increase of 7.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -28.05M → -39.24M (in $), with an average decrease of 18.9% per quarter

  • Vs DD

    In the last 1 year, Dupont De Nemours Inc has given 48.0% return, outperforming this stock by 77.8%

Performance

  • $1.79
    $2.09
    $2.07
    downward going graph

    13.77%

    Downside

    Day's Volatility :14.39%

    Upside

    0.72%

    downward going graph
  • $1.57
    $4.59
    $2.07
    downward going graph

    24.15%

    Downside

    52 Weeks Volatility :65.8%

    Upside

    54.9%

    downward going graph

Returns

PeriodDanimer Scientific IncSector (Materials)Index (Russel 2000)
3 Months
-13.03%
-5.2%
0.0%
6 Months
-32.79%
-1.0%
0.0%
1 Year
-29.83%
15.5%
6.3%
3 Years
-91.2%
23.4%
17.3%

Highlights

Market Capitalization
198.5M
Book Value
$3.24
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-1.89
Wall Street Target Price
4.6
Profit Margin
0.0%
Operating Margin TTM
-245.86%
Return On Assets TTM
-10.12%
Return On Equity TTM
-49.57%
Revenue TTM
50.6M
Revenue Per Share TTM
0.5
Quarterly Revenue Growth YOY
1.3%
Gross Profit TTM
2.8M
EBITDA
-97.7M
Diluted Eps TTM
-1.89
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.38
EPS Estimate Next Year
-1.35
EPS Estimate Current Quarter
-0.36
EPS Estimate Next Quarter
-0.34

Analyst Recommendation

Buy
    81%Buy
    18%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Danimer Scientific Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 122.22%

Current $2.07
Target $4.60

Company Financials

FY19Y/Y Change
Revenue
32.3M
-
Net Income
-19.5M
-
Net Profit Margin
-60.33%
-
FY20Y/Y Change
Revenue
47.3M
↑ 46.34%
Net Income
-12.6M
↓ 35.57%
Net Profit Margin
-26.56%
↑ 33.77%
FY21Y/Y Change
Revenue
58.7M
↑ 24.12%
Net Income
-60.1M
↑ 378.06%
Net Profit Margin
-102.31%
↓ 75.75%
FY22Y/Y Change
Revenue
53.2M
↓ 9.41%
Net Income
-179.8M
↑ 199.06%
Net Profit Margin
-337.78%
↓ 235.47%
Q1 FY22Q/Q Change
Revenue
14.7M
↓ 16.84%
Net Income
-26.4M
↑ 112.0%
Net Profit Margin
-178.97%
↓ 108.76%
Q2 FY22Q/Q Change
Revenue
12.7M
↓ 13.84%
Net Income
-30.4M
↑ 15.38%
Net Profit Margin
-239.67%
↓ 60.7%
Q3 FY22Q/Q Change
Revenue
10.4M
↓ 17.75%
Net Income
-94.9M
↑ 211.63%
Net Profit Margin
-908.08%
↓ 668.41%
Q4 FY22Q/Q Change
Revenue
15.3M
↑ 46.67%
Net Income
-28.1M
↓ 70.43%
Net Profit Margin
-183.05%
↑ 725.03%
Q1 FY23Q/Q Change
Revenue
11.9M
↓ 22.17%
Net Income
-36.6M
↑ 30.62%
Net Profit Margin
-307.22%
↓ 124.17%
Q2 FY23Q/Q Change
Revenue
12.9M
↑ 7.87%
Net Income
-39.2M
↑ 7.1%
Net Profit Margin
-305.02%
↑ 2.2%
FY19Y/Y Change
Total Assets
144.6M
-
Total Liabilities
128.0M
-
FY20Y/Y Change
Total Assets
546.2M
↑ 277.8%
Total Liabilities
107.3M
↓ 16.17%
FY21Y/Y Change
Total Assets
838.6M
↑ 53.53%
Total Liabilities
338.3M
↑ 215.32%
FY22Y/Y Change
Total Assets
712.3M
↓ 15.06%
Total Liabilities
334.7M
↓ 1.09%
Q1 FY22Q/Q Change
Total Assets
812.5M
↓ 3.12%
Total Liabilities
324.5M
↓ 4.08%
Q2 FY22Q/Q Change
Total Assets
790.7M
↓ 2.68%
Total Liabilities
318.9M
↓ 1.74%
Q3 FY22Q/Q Change
Total Assets
733.4M
↓ 7.25%
Total Liabilities
341.7M
↑ 7.15%
Q4 FY22Q/Q Change
Total Assets
712.3M
↓ 2.88%
Total Liabilities
334.7M
↓ 2.05%
Q1 FY23Q/Q Change
Total Assets
778.6M
↑ 9.32%
Total Liabilities
423.0M
↑ 26.4%
Q2 FY23Q/Q Change
Total Assets
744.3M
↓ 4.42%
Total Liabilities
414.0M
↓ 2.14%
FY18Y/Y Change
Operating Cash Flow
323.0K
-
Investing Cash Flow
2.8M
-
Financing Cash Flow
-453.0K
-
FY19Y/Y Change
Operating Cash Flow
-1.7M
↓ 617.96%
Investing Cash Flow
-49.1M
↓ 1846.46%
Financing Cash Flow
53.5M
↓ 11909.71%
FY20Y/Y Change
Operating Cash Flow
-13.8M
↑ 724.69%
Investing Cash Flow
-38.3M
↓ 22.07%
Financing Cash Flow
422.7M
↑ 690.08%
FY21Y/Y Change
Operating Cash Flow
-63.0M
↑ 356.35%
Investing Cash Flow
-336.2M
↑ 778.66%
Financing Cash Flow
306.2M
↓ 27.56%
FY22Y/Y Change
Operating Cash Flow
-61.8M
↓ 1.79%
Investing Cash Flow
-182.5M
↓ 45.72%
Financing Cash Flow
21.8M
↓ 92.9%
Q1 FY22Q/Q Change
Operating Cash Flow
-17.6M
↑ 13.42%
Investing Cash Flow
-58.9M
↓ 33.45%
Financing Cash Flow
78.0K
↓ 99.96%
Q2 FY22Q/Q Change
Operating Cash Flow
-19.8M
↑ 12.4%
Investing Cash Flow
-49.9M
↓ 15.32%
Financing Cash Flow
-7.0K
↓ 108.97%
Q3 FY22Q/Q Change
Operating Cash Flow
-20.2M
↑ 2.03%
Investing Cash Flow
-42.8M
↓ 14.18%
Financing Cash Flow
23.0M
↓ 328114.29%
Q4 FY22Q/Q Change
Operating Cash Flow
-4.3M
↓ 78.92%
Investing Cash Flow
-30.9M
↓ 27.94%
Financing Cash Flow
-1.3M
↓ 105.57%
Q1 FY23Q/Q Change
Operating Cash Flow
-5.9M
↑ 37.84%
Investing Cash Flow
-16.4M
↓ 46.85%
Financing Cash Flow
91.5M
↓ 7251.48%
Q2 FY23Q/Q Change
Operating Cash Flow
-15.3M
↑ 160.63%
Investing Cash Flow
-6.6M
↓ 59.51%
Financing Cash Flow
-6.5M
↓ 107.11%

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Danimer Scientific Inc
Danimer Scientific Inc
5.08%
-32.79%
-29.83%
-91.2%
-91.2%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-4.1%
1.32%
21.77%
-4.85%
67.27%
Linde Plc
Linde Plc
-3.81%
5.92%
38.12%
56.36%
125.03%
Dupont De Nemours Inc
Dupont De Nemours Inc
-3.12%
5.61%
48.0%
34.44%
-42.24%
Sherwin-williams Company, The
Sherwin-williams Company, The
-5.58%
17.52%
24.57%
9.82%
67.43%
Ecolab Inc.
Ecolab Inc.
-7.87%
3.75%
17.3%
-15.23%
7.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Danimer Scientific Inc
Danimer Scientific Inc
9.17
NA
NA
-1.38
-0.5
-0.1
0.0
3.24
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
29.33
29.33
1.92
11.48
0.15
0.06
0.02
63.64
Linde Plc
Linde Plc
34.03
34.03
2.73
13.98
0.14
0.06
0.01
81.79
Dupont De Nemours Inc
Dupont De Nemours Inc
36.74
36.74
1.64
4.3
0.04
0.03
0.02
56.91
Sherwin-williams Company, The
Sherwin-williams Company, The
28.4
28.4
2.05
9.78
0.8
0.09
0.01
14.18
Ecolab Inc.
Ecolab Inc.
41.18
41.18
2.01
5.12
0.16
0.06
0.01
26.51
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Danimer Scientific Inc
Danimer Scientific Inc
Buy
$198.5M
-91.2%
9.17
0.0%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$63.7B
67.27%
29.33
16.88%
Linde Plc
Linde Plc
Buy
$189.8B
125.03%
34.03
17.2%
Dupont De Nemours Inc
Dupont De Nemours Inc
Buy
$34.2B
-42.24%
36.74
37.65%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$65.9B
67.43%
28.4
10.2%
Ecolab Inc.
Ecolab Inc.
Hold
$48.2B
7.62%
41.18
7.96%

Institutional Holdings

  • BlackRock Inc

    5.88%

  • Vanguard Group Inc

    4.90%

  • Teramo Advisors, LLC

    3.49%

  • Greenlight Capital, Inc

    2.50%

  • Amvescap Plc.

    1.97%

  • State Street Corporation

    1.82%

Company Information

danimer scientific, producer of biopolymers in bainbridge, ga – manufactures pha bioplastics from renewable, natural resources. danimer plastics are 100% biodegradable and compostable, and equal or exceed petroleum-based plastic commodities for price and performance. danimer, formerly mhg (meredian holdings group), along with agrocrush, create bioplastic feedstock from cold pressed canola oil, enabling global brand owners to utilize environmentally responsible materials in products that consumers purchase every day. danimer makes commercial grade pha using world-class production systems, offering a scalable, durable, and cost effective material that reduces manufacturing dependence on non-renewable, diminishing resources. danimer also offers specialty toll manufacturing at their facility. danimer provides their state of the art production equipment, laboratories, material handling and logistics, as well as their fully trained and experienced staff to other companies.. danimer uses the

Organization
Danimer Scientific Inc
Employees
271
CEO
Mr. Stephen E. Croskrey
Industry
Basic Materials

Discover More

FAQs